脓毒症危重患者的感染源特异性宿主反应与结局:一项前瞻性队列研究
本研究基于MARS前瞻性队列,在621例脓毒症患者中检测16种反映关键宿主反应通路的血浆生物标志物,并在335例亚组中比较血白细胞转录组;在全部2019例脓毒症队列中比较临床特征与生存。结果显示腹部脓毒症相较呼吸道感染炎症与细胞因子反应更强、血管完整性丧失和凝血激活更明显;泌尿、心血管和皮肤感染以内皮细胞激活突出,中枢神经系统感染的宿主反应异常最少;白细胞转录组在腹部与肺部感染重叠最大(76%共同);校正混杂因素后感染源仍是30天死亡的独立贡献因素(未校正 p=0.001,校正 p=0.028)。作者认为脓毒症异质性部分由感染源特异性宿主反应失调解释,选择免疫调节药物试验患者时应考虑感染源。
要点
- 腹部脓毒症相较呼吸道感染呈现更强的炎症与细胞因子反应、血管完整性丧失和凝血激活。
- 泌尿、心血管和皮肤感染以内皮细胞激活突出,中枢神经系统感染的宿主反应异常最少。
- 腹部与肺部感染的白细胞转录组重叠最大(76%共同),但在止血、细胞因子信号、固有与适应性免疫及代谢通路上存在明显差异。
- 校正混杂因素后,感染源仍是30天死亡的独立贡献因素(未校正 p=0.001,校正 p=0.028)。
- 作者认为脓毒症异质性部分由感染源特异性宿主反应失调解释,选择免疫调节药物试验患者时应考虑感染源。
适用人群与场景
- MARS前瞻性队列中入ICU时(<24 h)存在单一已知感染源的脓毒症患者:血浆生物标志物队列621例,转录组亚组335例,全脓毒症队列2019例。
研究设计与关键结果
- 研究类型:前瞻性队列研究(MARS队列);血浆生物标志物队列621例,血白细胞转录组亚组335例,全脓毒症队列2019例。
- 血浆生物标志物队列感染源构成:呼吸道334例(53.8%)、腹部159例(25.6%)、泌尿44例(7.1%)、心血管41例(6.6%)、中枢神经系统18例(2.9%)、皮肤25例(4%)。
- 腹部脓毒症相较呼吸道感染呈现更强的炎症与细胞因子反应、血管完整性丧失和凝血激活。
- 内皮细胞激活在泌尿、心血管和皮肤感染中突出,中枢神经系统感染的宿主反应异常最少。
- 白细胞转录组在腹部与肺部感染重叠最大(76%共同),在止血、细胞因子信号、固有与适应性免疫及代谢转录通路上存在来源间明显差异。
- 校正混杂因素后,感染源仍是30天死亡的独立贡献因素(未校正 p=0.001,校正 p=0.028)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为脓毒症异质性部分由感染源特异性宿主反应失调解释,选择免疫调节药物试验患者时应考虑感染源。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: There is limited knowledge on how the source of infection impacts the host response to sepsis. We aimed to compare the host response in sepsis patients with a single, known source at admission (< 24 h) to the intensive care unit.
METHODS: From the molecular diagnosis and risk stratification of sepsis (MARS) prospective cohort, we measured 16 plasma host response biomarkers reflective of key host response pathways in 621 sepsis patients. In a subgroup (n = 335), blood leukocyte transcriptomes were compared between the sources. Differences in clinical patient profiles and survival were compared in the whole sepsis cohort (n = 2019).
RESULTS: The plasma biomarker cohort was categorized into sepsis originating from the respiratory tract (n = 334, 53.8%), abdomen (n = 159, 25.6%), urinary tract (n = 44, 7.1%), cardiovascular (n = 41, 6.6%), central nervous system (CNS) (n = 18, 2.9%), or skin (n = 25, 4%). This analysis revealed stronger inflammatory and cytokine responses, loss of vascular integrity and coagulation activation in abdominal sepsis relative to respiratory. Endothelial cell activation was prominent in urinary, cardiovascular and skin infections, while CNS infection was associated with the least host response aberrations. The leukocyte transcriptional response showed the largest overlap between abdominal and pulmonary infections (76% in common); notable differences between the sources were detected regarding hemostasis, cytokine signaling, innate and adaptive immune, and metabolic transcriptional pathways. After adjustment for confounders, the source of infection remained an independent contributor to 30-day mortality (unadjusted p = 0.001, adjusted p = 0.028).
CONCLUSION: Sepsis heterogeneity is partly explained by source-specific host response dysregulations and should be considered when selecting patients for trials testing immune modulatory drugs.
参考来源
- Peters-Sengers H, Butler JM, Uhel F, et al. Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2021. PMID: 34902047. doi:10.1007/s00134-021-06574-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。